Referenced in the #AACRCOVIDReport: How to Provide the Needed Protection from #COVID19 to Patients with Hematologic Malignancies by Ribas et al. https://t.co/g3XKSEGeCc
Referenced in the #AACRCOVIDReport: How to Provide the Needed Protection from #COVID19 to Patients with Hematologic Malignancies. https://t.co/p9a7vI9hnr
Great paper by @MadhavDhodapkar and team. How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies https://t.co/hMWdtYPmio
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies #lymphoma #lymsm https://t.co/MVT2b10MhH
RT @_TanyaBondar_: In an open letter to the @CDCDirector @DrRochelleWalensky, the @AACR advocates for #COVID19 vaccine boosters for househo…
RT @_TanyaBondar_: In an open letter to the @CDCDirector @DrRochelleWalensky, the @AACR advocates for #COVID19 vaccine boosters for househo…
RT @_TanyaBondar_: In an open letter to the @CDCDirector @DrRochelleWalensky, the @AACR advocates for #COVID19 vaccine boosters for househo…
RT @_TanyaBondar_: In an open letter to the @CDCDirector @DrRochelleWalensky, the @AACR advocates for #COVID19 vaccine boosters for househo…
RT @_TanyaBondar_: In an open letter to the @CDCDirector @DrRochelleWalensky, the @AACR advocates for #COVID19 vaccine boosters for househo…
In an open letter to the @CDCDirector @DrRochelleWalensky, the @AACR advocates for #COVID19 vaccine boosters for household members and caregivers of patients with cancer: https://t.co/qzFpYbWOFu This is based on the analysis done by this @BCD_AACR study: h
#ICYMI: Protecting patients with heme malignancies from #COVID19. Antoni Ribas et al review vaccine response in thousands of patients and present urgent recommendations for additional measures and research. https://t.co/6UwaUzH7zV. @MadhavDhodapkar @CampK
RT @jstclair1: "A similarly low rate of seroconversion is evident in series reporting on patients with non Hodgkin lymphoma…
RT @jstclair1: "A similarly low rate of seroconversion is evident in series reporting on patients with non Hodgkin lymphoma…
"A similarly low rate of seroconversion is evident in series reporting on patients with non Hodgkin lymphoma (NHL)" @LLSusa @AmericanCancer
Literature review of 24 series shows that patients with blood cancers, who already are particularly vulnerable to #COVID19, do not develop strong immunity after vaccination & need additional layers of protection. https://t.co/sr5DV3UMPf
#ICYMI: Protecting patients with heme malignancies from #COVID19 - Antoni Ribas et al review vax response in thousands of patients and present urgent recommendations for additional measures and research. https://t.co/rHIW0GlxI9. @MadhavDhodapkar @CampKatie
'To provide them the needed additional protection from COVID-19, it is imperative to achieve a 100% full immunization rate in health care workers and adult caretakers, and foster research to test higher doses and repeated rounds of COVID-19 vaccines' https
@VincentRK Booster shot for families and caregivers of the immunocompromised, to prevent transmission both ways. From https://t.co/RlwT5yOJtO
Blood cancer patients are most vulnerable to COVID-19 infection. Overview of responses to #COVID19 vaccines of 4800 patients, 700 healthy controls from 18 papers show impaired antibody response to vaccination: https://t.co/evxq8eu5uk
RT @MadhavDhodapkar: Honored to be a part of this work. Protecting immune compromised may be key to preventing variants and ending the pand…
RT @MadhavDhodapkar: Honored to be a part of this work. Protecting immune compromised may be key to preventing variants and ending the pand…
RT @MadhavDhodapkar: Honored to be a part of this work. Protecting immune compromised may be key to preventing variants and ending the pand…
RT @LeukDocJZ: A fantastic review & compilation of data re: antibody responses to #COVID19 vaccinations in heme malignancies in @BCD_AACR.…
RT @LeukDocJZ: A fantastic review & compilation of data re: antibody responses to #COVID19 vaccinations in heme malignancies in @BCD_AACR.…
RT @LeukDocJZ: A fantastic review & compilation of data re: antibody responses to #COVID19 vaccinations in heme malignancies in @BCD_AACR.…
A fantastic review & compilation of data re: antibody responses to #COVID19 vaccinations in heme malignancies in @BCD_AACR. Agree 💯 w/ the authors that 100% of HCW, staff & caregivers for these pts should be fully vaccinated & prioritized for h
Honored to be a part of this work. Protecting immune compromised may be key to preventing variants and ending the pandemic.
Just published! Protecting patients with heme malignancies from #COVID19: Antoni Ribas et al review vax response in thousands of patients and present urgent recommendations for additional measures and research. https://t.co/Po4A6458SN. @MadhavDhodapkar @C